Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Holzer, P; Jocic, M; Cabré, F; Mauléon, D.
Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses.
INFLAMM RESEARCH 2001 50: 602-608. Doi: 10.1007/PL00000241
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leading authors Med Uni Graz
Holzer Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVE: Since assessment of the acute gastrotoxicity of nonsteroidal antiinflammatory drugs (NSAIDs) in rats requires high doses of the drugs, we sought to establish an experimental model with which this adverse NSAID effect can be estimated at therapy-relevant doses. METHODS: The study was performed with racemic flurbiprofen-trometamol (R/S-FBP), its pure enantiomers S-FBP and R-FBP, and racemic ketoprofen-trometamol (R/S-KP). Two hours after administration of FBP or KP to Sprague-Dawley rats, HCl (0.5 M, 10 ml/kg) was given intragastrically (IG), and the haemorrhagic lesion area in the gastric mucosa quantified 1 h post-HCI. RESULTS: FBP amplified gastric acid injury in a dose-related manner, the rank order of potency being S-FBP > R/S-FBP >> R-FBP. While less than 1 micromol/kg S-FBP and R/S-FBP aggravated acid injury, doses up to 50 micromol/kg failed to cause appreciable damage without subsequent HCl challenge. Similar observations were made with R/S-KP which at doses of > or = 1 micromol/kg aggravated gastric acid injury. There was no significant difference in the gastrotoxicity of FBP when the drug was administered subcutaneously or IG, whereas subcutaneously injected R/S-KP was slightly more toxic than IG R/S-KP. CONCLUSIONS: These data show that FBP- and KP-induced amplification of acid injury in the rat gastric mucosa is a sensitive assay whereby, with single drug dosing, the gastrotoxic potential of these and other NSAIDs may be estimated at therapy-relevant doses that in humans threaten mucosal integrity only following chronic use.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Anti-Inflammatory Agents, Non-Steroidal - administration and dosage
Comparative Study - administration and dosage
Cyclooxygenase 1 - administration and dosage
Cyclooxygenase 2 - administration and dosage
Cyclooxygenase 2 Inhibitors - administration and dosage
Cyclooxygenase Inhibitors - pharmacology
Female - pharmacology
Flurbiprofen - administration and dosage
Gastric Mucosa - pathology
Injections, Subcutaneous - pathology
Intubation, Gastrointestinal - pathology
Isoenzymes - drug effects
Ketoprofen - administration and dosage
Membrane Proteins - administration and dosage
Nitrobenzenes - pharmacology
Prostaglandin-Endoperoxide Synthases - drug effects
Rats - drug effects
Rats, Sprague-Dawley - drug effects
Research Support, Non-U.S. Gov't - drug effects
Stereoisomerism - drug effects
Stomach Ulcer - chemically induced
Sulfonamides - pharmacology

Find related publications in this database (Keywords)
flurbiprofen
ketoprofen
NS-398
gastrotoxicity
therapy-relevant dosage
© Med Uni GrazImprint